See All Slides - tctmd.com

Slides

Presentation TCT 2012

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Presenter: Neil Weissman

October 22, 2012

Presentation TCT 2012

Rationale for Dedicated Bifurcation Stents, and Propsed Classification

Presenter: John Ormiston

October 22, 2012

Presentation TCT 2012

Gene Therapy for Peripheral Arterial Disease: Status Update

Presenter: Timothy Henry

October 22, 2012

Presentation TCT 2012

Position 3. Ischemia Matters: Use PCI with DES Principally to Eliminate Ischemia!

Presenter: Bernard De Bruyne

October 22, 2012

Presentation TCT 2012

The SOURCE Multicenter EU Registries (Including XT)

Presenter: Martyn Thomas

October 22, 2012

Presentation TCT 2012

Step 3: Intellectual Property

Presenter: Casey McGlynn

October 22, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

Presentation TCT 2012

Below the Knee Intervention: Technique, Biological Considerations, and Beyond

Presenter: Hans Krankenberg

October 22, 2012

Presentation TCT 2012

When Do I Prefer Transsubclavian/Axillary Alternative Access for TAVR?

Presenter: Jean-Claude Laborde

October 22, 2012

Presentation TCT 2012

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Presenter: Alessandro Bortone

October 22, 2012

Advertisement

Slides

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Rationale for Dedicated Bifurcation Stents, and Propsed Classification

Gene Therapy for Peripheral Arterial Disease: Status Update

Position 3. Ischemia Matters: Use PCI with DES Principally to Eliminate Ischemia!

The SOURCE Multicenter EU Registries (Including XT)

Step 3: Intellectual Property

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Below the Knee Intervention: Technique, Biological Considerations, and Beyond

When Do I Prefer Transsubclavian/Axillary Alternative Access for TAVR?

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content